查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1912751

家用采血针市场按产品类型、规格、材质和销售管道－全球预测（2026-2032 年）

Home Use Lancets Market by Product Type, Gauge, Material, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，家用采血针市场价值将达到 14.2 亿美元，到 2026 年将成长至 14.9 亿美元，到 2032 年将达到 22.8 亿美元，复合年增长率为 6.94%。

主要市场统计数据
基准年 2025 14.2亿美元
预计年份：2026年 14.9亿美元
预测年份：2032年 22.8亿美元
复合年增长率 (%) 6.94%

全面概述家用采血针的发展趋势，包括产品设计、使用者需求、法规环境和分销趋势，这些因素共同影响着设备的普及应用。

家用采血针结合了符合人体工学的设计、安全特性和使用者信心，仍然是支持日常糖尿病自我管理实践的关键组成部分。本报告将采血针产品置于更广泛的患者需求、临床指南和分销管道变化等影响产品选择和应用的因素中进行整体情况变化的设备偏好、监管预期和用户群特征如何共同塑造产品开发重点和商业策略。

产品设计、监管、供应链韧性和数位健康整合等领域的新兴趋势正在重新定义《采血针》生态系统的优先事项和商业策略。

采血针市场正经历着变革性的转变，使用者体验优先、监管日益严格以及数位化医疗的整合是推动变革的主要因素，这正在重塑製造商和经销商的产品设计和通路策略。使用者对疼痛感最小化、插入深度一致性和操作直觉性的期望，使得自动化解决方案和先进的使用者介面变得愈发重要，促使产品蓝图更加重视效能和使用者体验的舒适度。

2025年美国关税调整对家用采血设备製造商和经销商的采购、采购策略和竞争利润率的影响

2025年美国关税环境对家用医疗设备的製造商、进口商和下游经销商构成重大挑战，并对业务营运和定价产生连锁反应。重新设计的关税正在影响零件和成品的成本结构，进而影响采购选择和库存策略，因为企业正在寻求降低到岸成本。因此，采购部门正在重新评估其供应商组合，并考虑近岸外包和多元化经营，以稳定供应链并维持可预测的交货期。

将产品设计、最终用户需求、分销管道、规格选择和材料选择与产品策略和用户采纳联繫起来的多维度細項分析

产品细分洞察突显了创新与商业性重点的整合领域，以及持续存在的未满足需求。产品类型涵盖从手动设备到自动采血系统，其中自动解决方案明显区分了非回缩式设计和回缩式型号，后者优先考虑使用后针头的隐藏。同时，手动设备又分为非弹簧式和弹簧式设计，后者旨在实现稳定且便利的操作。这种层级式产品分类系统影响设计者的优先事项，因为他们需要在触觉回馈、深度控制和安全处置之间寻求平衡，并驱动着製造商的研发策略。

区域策略概述，比较美洲、欧洲、中东和非洲以及亚太地区的监管复杂性、流通结构和消费者偏好。为目标市场进入和成长提供指南。

区域趋势影响监管要求、分销复杂性和消费者偏好，从而为每个主要地理区域丛集创造了独特的策略要务。在美洲，成熟的糖尿病照护管道和广泛的零售药房网路确保了产品的快速供应和与消费者的直接互动。同时，某些地区的健保报销环境和采购竞标也会影响定价策略和通路优先顺序。在该地区运营的製造商往往注重便捷的包装、患者教育材料和临床合作项目，以提高患者的用药依从性。

主要製造商之间的竞争格局和策略性倡议强调产品差异化、伙伴关係和分销策略，以创造可持续的商业性优势。

领先製造商之间的竞争格局呈现出多元化的态势，这些态势体现在产品创新、策略联盟和分销管道等方面。主要参与企业正致力于研发差异化的安全功能、精密的深度控制机制以及包装创新，以提高病患的理解能力和确保处置安全性。与数位医疗公司和血糖监测系统供应商的合作日益普遍，从而实现整合的使用者体验和交叉促销，使设备的用途超越一次性使用。

将产品创新、全通路分销和供应链韧性相结合，以实现永续竞争优势，这其中存在着切实的策略挑战。

产业领导者应优先考虑整合产品创新、通路执行和监管准备的策略，以获取长期价值。人体工学和低痛感机制的投资能够增强产品在高频用户群中的定位，而模组化设计方法则能够实现快速迭代和对不同管理体制的本地化调整。赋能跨职能团队，将设计、监管和供应链决策连结起来，可以减少因合规性主导的产品变更而产生的摩擦，并加快对关税和采购衝击的反应速度。

我们采用透明的多资讯来源调查方法，结合关键相关人员访谈、监管审查和三角验证分析，以确保研究结果切实可行且经得起推敲。

本研究采用多层次调查方法，整合了主要研究结果和次要讯息，强调资料的完整性、可重复性和专家检验。主要资料来源包括对医疗设备设计师、采购经理、药剂师和熟悉自我给药实务的临床医生进行的结构化访谈。这些访谈提供了深入的定性分析，将观察到的商业性模式置于具体的背景中，重点关注易用性、分销管道特征和营运限制。访谈样本的选择优先考虑了地域多样性和不同规模的组织，以反映不同的营运实际情况。

综合分析表明，卓越的设计、灵活的监管适应能力和成熟的分销管道是家用采血设备实现可持续成功的基础。

本报告总结了参与家用采血针设计、分销和采购的相关人员最重要的见解，重点阐述了用户体验、监管压力和不断变化的分销渠道如何共同塑造产品方向。自动化采血系统的进步和手动采血针设计的改进，提高了人们对无痛采血、安全性和性能稳定性的期望。同时，为了满足不同终端使用者的需求，例如孕妇、1 型糖尿病患者和第 2 型糖尿病患者，需要针对每个使用者群体量身定制价值提案。产品属性（例如规格和材料）与分销管道趋势之间的相互作用，会影响用户满意度和重购率。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依产品类型分類的家用采血针市场

  • 自动的
    • 非弹簧式
    • 弹簧型
  • 手动输入
    • 非弹簧式
    • 弹簧型

第九章 家用采血针市场（依规格划分）

  • 28号口径
  • 30号口径
  • 31号口径
  • 32号口径

第十章 家用采血针市场（依材料分类）

  • 塑胶
  • 防锈的

第十一章 家用采血针市场销售管道

  • 在线的
  • 药局

第十二章：各地区家用采血针市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 家用采血针市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 各国家用采血针市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章美国家庭采血针市场

第十七章：中国家用采血针市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Arkray, Inc.
  • Ascensia Diabetes Care Holdings AG
  • B. Braun Melsungen AG
  • F. Hoffmann-La Roche AG
  • LifeScan, LLC
  • Menarini Diagnostics Srl
  • Nipro Corporation
  • Owen Mumford Ltd.
  • Terumo Corporation
Product Code: MRR-AE420CB13A75

The Home Use Lancets Market was valued at USD 1.42 billion in 2025 and is projected to grow to USD 1.49 billion in 2026, with a CAGR of 6.94%, reaching USD 2.28 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.42 billion
Estimated Year [2026] USD 1.49 billion
Forecast Year [2032] USD 2.28 billion
CAGR (%) 6.94%

A comprehensive orientation to home-use lancet dynamics that establishes product design, user needs, regulatory context, and distribution trends shaping device adoption

Home-use lancets remain a critical component of self-monitoring practices, blending ergonomic design, safety features, and user confidence to support daily diabetes management. This report introduces the landscape by situating lancet products within broader patient needs, clinical guidance, and distribution shifts that influence product choice and adoption. It explores how evolving device preferences, regulatory expectations, and user demographics converge to shape product development priorities and commercial strategies.

The introduction frames the technology continuum from simple manual devices to increasingly automated solutions that prioritize comfort, consistency, and reduced needlestick risk. It also notes the influence of adjacent innovations such as blood glucose monitoring platforms and telehealth protocols that reinforce the centrality of reliable capillary sampling. Throughout, the discussion highlights how human factors engineering and supply chain resilience are as consequential as material and gauge selection when evaluating product viability.

This section establishes the report's analytical approach, emphasizing comparative evaluation across product design categories and end-user segments. It underscores the importance of integrating clinical usability studies, regulatory guidance, and distribution behavior in forming practical recommendations. By grounding the analysis in real-world user requirements and operational constraints, the introduction positions readers to interpret subsequent sections with a focus on actionable outcomes and strategic alignment.

Emerging forces in product design, regulation, supply resilience, and digital health integration that are redefining priorities and commercial strategies across the lancet ecosystem

The lancet landscape is experiencing transformative shifts driven by user experience priorities, regulatory tightening, and digital health integration, reshaping how manufacturers and distributors approach product design and channel strategies. User expectations for pain minimization, consistency of puncture depth, and intuitive operation are elevating the importance of automated solutions and refined user interfaces, prompting product roadmaps that emphasize both performance and emotional comfort.

Regulatory frameworks are tightening in major markets, raising requirements for labeling, safety mechanisms, and post-market surveillance. These developments in policy reinforce manufacturers' need to embed traceability and adverse event reporting capabilities in product lifecycles. Concurrently, the rise of integrated personal health ecosystems-where lancets feed into connected glucose monitoring and telemedicine workflows-creates a demand for compatibility, standardized user instructions, and packaging that supports multi-device households.

Supply chain resilience and sustainability considerations are also catalyzing innovation. Material choices and design for recyclability are becoming important differentiators, as procurement teams and informed consumers look to reduce single-use environmental footprints. Finally, distribution is fragmenting: direct-to-consumer channels are complemented by pharmacy networks and digital retailers, requiring omnichannel strategies that balance clinical guidance, consumer education, and efficient fulfillment. Together, these shifts are redefining priorities for product development, regulatory planning, and commercial execution.

How the 2025 US tariff adjustments are reshaping procurement, sourcing strategies, and competitive margins for manufacturers and distributors of home-use blood sampling devices

The United States tariff landscape in 2025 has introduced material considerations for manufacturers, importers, and downstream distributors of home-use medical devices, with cascading operational and pricing implications. Tariff redesigns affect cost structures for components and finished products, influencing sourcing choices and inventory strategies as companies seek to mitigate elevated landed costs. As a result, procurement teams are reevaluating supplier portfolios and considering nearshoring or diversification to stabilize supply lines and maintain predictable fulfillment windows.

Tariff-related cost pressures also alter competitive positioning among players who rely on international manufacturing. Organizations with vertically integrated operations or diversified production footprints are better insulated against import duty volatility, while smaller suppliers may experience squeezes on margin that constrain investment in design improvements or regulatory readiness. In some cases, distributors adjust pricing frameworks or absorb portions of duty increases temporarily to preserve customer relationships, creating short-term margin trade-offs.

Regulatory compliance costs interact with tariff effects to shape go-to-market timing and packaging decisions. Companies reassess whether to consolidate SKUs, redesign packaging for cost-effective cross-border compliance, or localize certain production steps to reduce tariff exposure. These combined forces underscore the need for dynamic scenario planning, proactive customs classification reviews, and heightened collaboration between regulatory, procurement, and commercial teams to preserve continuity and protect end-user access to critical self-monitoring tools.

A multidimensional segmentation analysis that links product designs, end-user needs, sales channels, gauge selection, and material choices to product strategy and user adoption

Insight into product segmentation clarifies where innovation and commercial focus are converging and where unmet needs persist. The product type spectrum ranges from manual devices to automated lancing systems; within automatic solutions there is a clear distinction between non-retraction designs and retraction-enabled models that prioritize needle concealment post-use, while manual alternatives are split between non spring loaded options and spring loaded designs that enhance consistency and ease of activation. This layered product taxonomy influences manufacturer R&D priorities, as designers balance tactile feedback, depth control, and safe disposal features.

End-user segmentation further refines demand dynamics. Users managing gestational glucose monitoring bring distinct frequency and comfort concerns compared with individuals with type 1 diabetes who often require higher-frequency sampling and therefore place premium value on consistency and low-pain profiles, while people with type 2 diabetes may prioritize affordability and ease of use for less intensive monitoring routines. Channel segmentation reveals evolving purchase behaviors: online pathways include direct-to-consumer procurement and purchases through third-party retailers, whereas pharmacy channels encompass both chain and independent outlets that differ in stocking strategies, pharmacist counseling roles, and point-of-sale education.

Technical attributes including gauge options-spanning 28 gauge to 32 gauge-drive perceptions of pain and sample adequacy, with smaller gauge numbers typically associated with larger needle diameters. Material choices between plastic and stainless steel affect tactile feel, recyclability, and cost profiles, shaping procurement decisions for health systems and consumer preferences for perceived durability. Together, these segmentation lenses provide a multidimensional framework for assessing product fit, competitive differentiation, and targeted messaging.

A regional strategic brief that contrasts regulatory complexity, distribution structures, and consumer preferences across the Americas, Europe Middle East & Africa, and Asia-Pacific for targeted market entry and growth

Regional dynamics shape regulatory expectations, distribution complexity, and consumer preferences, creating distinct strategic imperatives across major geographic clusters. In the Americas, established diabetes care pathways and broad retail pharmacy networks support rapid product availability and significant direct-to-consumer engagement, while reimbursement environments and procurement tenders in some jurisdictions influence pricing strategies and channel prioritization. Manufacturers operating in this region often emphasize convenient packaging, patient education materials, and partnership programs with clinical organizations to drive adherence.

In Europe, the Middle East & Africa region, regulatory harmonization efforts and national-level medical device directives create a mosaic of compliance requirements that favor manufacturers with robust regulatory affairs capabilities and localized market entry plans. Distribution channels vary widely, from consolidated chain pharmacies in some markets to decentralized independent outlets in others, necessitating adaptable logistics and tailored pharmacist training initiatives. Cultural preferences and climate considerations also influence material selection and packaging formats.

Across the Asia-Pacific region, rapid adoption of digital health tools and strong manufacturing ecosystems create both opportunity and competition. High-volume distribution channels, growing online retail penetration, and diverse patient profiles require nimble supply strategies and scalable production capacity. In several markets, price sensitivity is balanced by strong demand for convenience and minimized pain, encouraging manufacturers to offer tiered product portfolios that address both premium and value segments. These regional distinctions inform prioritization of investment, regulatory planning, and channel partnerships.

Competitive patterns and strategic maneuvers among leading manufacturers emphasizing product differentiation, partnerships, and distribution plays that drive enduring commercial advantage

Competitive dynamics among leading manufacturers reveal a mix of product innovation, strategic partnerships, and distribution-focused plays that shape the competitive landscape. Key players are investing in differentiated safety features, refined depth-control mechanisms, and packaging innovations that improve patient comprehension and disposal safety. Collaborations with digital health firms and glucose monitoring system providers are increasingly common, enabling integrated user experiences and cross-promotional opportunities that extend device relevance beyond single-use interactions.

Mergers, acquisitions, and licensing agreements remain important mechanisms for accessing advanced technologies and regional distribution networks. Acquirers often target companies with proprietary user-centric designs or regulatory approvals in strategic territories, accelerating time-to-market for enhanced lancet portfolios. At the same time, alliances with pharmacy chains and e-commerce platforms secure shelf presence and optimize fulfillment logistics, reinforcing channels that drive recurring purchases.

Smaller specialized manufacturers are leveraging nimble engineering cycles to pilot novel materials and recyclable packaging, carving niche positions around sustainability claims or premium comfort. Pricing strategies vary by distribution channel and customer segment, with value offerings aimed at high-volume users and premium lines focused on low-pain automated experiences. These competitive patterns suggest that sustained investment in product differentiation, regulatory capability, and omnichannel presence will determine which companies convert product innovation into durable commercial advantage.

Actionable strategic imperatives for manufacturers and distributors to align product innovation, omnichannel distribution, and supply resilience for durable competitive performance

Industry leaders should prioritize integrated strategies that align product innovation with channel execution and regulatory readiness to capture long-term value. Investing in ergonomics and low-pain mechanisms can strengthen product positioning among high-frequency users while modular design approaches enable faster iteration and localized adaptation for diverse regulatory regimes. Strengthening cross-functional teams that link design, regulatory affairs, and supply chain decision-making reduces the friction of compliance-driven product changes and accelerates responsiveness to tariff or sourcing shocks.

Expanding omnichannel capabilities is essential. Direct-to-consumer platforms should be complemented by robust pharmacy partnerships and third-party retail distribution to balance reach and clinical counsel. Initiatives that support pharmacist education and patient onboarding tools will enhance adherence and product perception at the point of care. Simultaneously, pilot programs that integrate lancets into connected glucose monitoring ecosystems create opportunities for bundled solutions that increase customer lifetime value and improve clinical data capture.

Operationally, manufacturers should pursue supplier diversification and scenario-based procurement models to mitigate import duty and logistical risks. Sustainable material strategies, including recyclable packaging and reduced single-use plastics, can strengthen brand differentiation and anticipate tightening environmental regulations. Finally, consider targeted M&A or licensing to acquire specialty designs or regional market access, ensuring that expansion accelerates capability rather than dilutes focus. Executed together, these measures will help organizations convert product strengths into resilient commercial performance.

A transparent, multi-source research methodology combining primary stakeholder interviews, regulatory review, and triangulated analysis to ensure actionable and defensible findings

This research synthesizes primary insights and secondary sources through a layered methodology that emphasizes data integrity, reproducibility, and expert validation. Primary inputs include structured interviews with device designers, procurement leads, pharmacists, and clinicians experienced in self-monitoring practices. These conversations focused on usability, channel behaviors, and operational constraints, providing qualitative depth that contextualizes observed commercial patterns. Interview sampling prioritized geographic diversity and a range of organizational sizes to capture differing operational realities.

Secondary research incorporated regulatory documents, product literature, and peer-reviewed clinical ergonomics studies to map compliance trajectories and user-centric design benchmarks. Trade publications and logistics performance indicators were consulted to understand distribution trends and supply chain stressors. Data triangulation techniques were applied to reconcile differences between stakeholder accounts and documented operational metrics, ensuring conclusions reflect convergent evidence rather than single-source assertions.

Analytical steps included segmentation mapping, scenario analysis for tariff and sourcing variations, and comparative feature benchmarking across product types, gauges, and material choices. Quality assurance encompassed cross-validation of interview summaries with source participants, independent review by technical subject-matter experts, and consistency checks to ensure that regulatory references were current as of the final analysis. The methodology prioritizes transparent sourcing and defensible inference to support practical decision-making.

Consolidated findings that emphasize design excellence, regulatory agility, and channel sophistication as the pillars of sustainable success in home-use blood sampling devices

This report consolidates the most consequential insights for stakeholders engaged in the design, distribution, and procurement of home-use lancets, underscoring how user experience, regulatory pressures, and channel evolution jointly shape product trajectories. Advances in automated lancing systems and refinements to manual designs are raising expectations for low-pain sampling, safety, and consistent performance, while diverse end-user needs require tailored value propositions across gestational, type 1, and type 2 user profiles. The interaction between product attributes such as gauge and material and channel dynamics influences user satisfaction and repeat purchasing.

Regional and tariff-related forces highlight the strategic importance of adaptable supply chains, regulatory foresight, and targeted distribution partnerships. Manufacturers that couple ergonomic innovation with regulatory competence and omnichannel execution are positioned to capitalize on shifting preferences. Sustainability and lifecycle considerations are becoming differentiators, prompting product teams to weigh material selection and end-of-life handling in future roadmaps.

In sum, success in the home-use lancet domain will favor organizations that integrate human-centered design, compliance agility, and channel sophistication into cohesive strategies. Stakeholders should act on the report's insights to refine product portfolios, optimize distribution models, and strengthen resilience against external shocks, thereby enhancing user outcomes and long-term operational stability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home Use Lancets Market, by Product Type

  • 8.1. Automatic
    • 8.1.1. Non Retraction
    • 8.1.2. Retraction
  • 8.2. Manual
    • 8.2.1. Non Spring Loaded
    • 8.2.2. Spring Loaded

9. Home Use Lancets Market, by Gauge

  • 9.1. 28 Gauge
  • 9.2. 30 Gauge
  • 9.3. 31 Gauge
  • 9.4. 32 Gauge

10. Home Use Lancets Market, by Material

  • 10.1. Plastic
  • 10.2. Stainless Steel

11. Home Use Lancets Market, by Sales Channel

  • 11.1. Online
  • 11.2. Pharmacy

12. Home Use Lancets Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Home Use Lancets Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Home Use Lancets Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Home Use Lancets Market

16. China Home Use Lancets Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Arkray, Inc.
  • 17.7. Ascensia Diabetes Care Holdings AG
  • 17.8. B. Braun Melsungen AG
  • 17.9. F. Hoffmann-La Roche AG
  • 17.10. LifeScan, LLC
  • 17.11. Menarini Diagnostics S.r.l.
  • 17.12. Nipro Corporation
  • 17.13. Owen Mumford Ltd.
  • 17.14. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL HOME USE LANCETS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL HOME USE LANCETS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL HOME USE LANCETS MARKET SIZE, BY GAUGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL HOME USE LANCETS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL HOME USE LANCETS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON RETRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON RETRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON RETRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL HOME USE LANCETS MARKET SIZE, BY RETRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL HOME USE LANCETS MARKET SIZE, BY RETRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL HOME USE LANCETS MARKET SIZE, BY RETRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL HOME USE LANCETS MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL HOME USE LANCETS MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL HOME USE LANCETS MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON SPRING LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON SPRING LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL HOME USE LANCETS MARKET SIZE, BY NON SPRING LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL HOME USE LANCETS MARKET SIZE, BY SPRING LOADED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL HOME USE LANCETS MARKET SIZE, BY SPRING LOADED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL HOME USE LANCETS MARKET SIZE, BY SPRING LOADED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL HOME USE LANCETS MARKET SIZE, BY 28 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL HOME USE LANCETS MARKET SIZE, BY 28 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL HOME USE LANCETS MARKET SIZE, BY 28 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL HOME USE LANCETS MARKET SIZE, BY 30 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL HOME USE LANCETS MARKET SIZE, BY 30 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL HOME USE LANCETS MARKET SIZE, BY 30 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL HOME USE LANCETS MARKET SIZE, BY 31 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL HOME USE LANCETS MARKET SIZE, BY 31 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL HOME USE LANCETS MARKET SIZE, BY 31 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL HOME USE LANCETS MARKET SIZE, BY 32 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL HOME USE LANCETS MARKET SIZE, BY 32 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL HOME USE LANCETS MARKET SIZE, BY 32 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL HOME USE LANCETS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL HOME USE LANCETS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL HOME USE LANCETS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL HOME USE LANCETS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL HOME USE LANCETS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL HOME USE LANCETS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL HOME USE LANCETS MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL HOME USE LANCETS MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL HOME USE LANCETS MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL HOME USE LANCETS MARKET SIZE, BY PHARMACY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL HOME USE LANCETS MARKET SIZE, BY PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL HOME USE LANCETS MARKET SIZE, BY PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL HOME USE LANCETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS HOME USE LANCETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 62. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 69. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 70. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 90. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 91. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. MIDDLE EAST HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 97. AFRICA HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 98. AFRICA HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. AFRICA HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOME USE LANCETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 112. ASEAN HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 113. ASEAN HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. ASEAN HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 115. GCC HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GCC HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. GCC HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 118. GCC HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 119. GCC HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 120. GCC HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. GCC HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPEAN UNION HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 133. BRICS HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 134. BRICS HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. BRICS HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. G7 HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. G7 HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. G7 HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 139. G7 HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 140. G7 HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 141. G7 HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. G7 HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 143. NATO HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. NATO HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. NATO HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 146. NATO HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 147. NATO HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 148. NATO HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. NATO HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL HOME USE LANCETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 155. UNITED STATES HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 156. UNITED STATES HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 157. UNITED STATES HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA HOME USE LANCETS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA HOME USE LANCETS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA HOME USE LANCETS MARKET SIZE, BY AUTOMATIC, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA HOME USE LANCETS MARKET SIZE, BY MANUAL, 2018-2032 (USD MILLION)
  • TABLE 162. CHINA HOME USE LANCETS MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 163. CHINA HOME USE LANCETS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 164. CHINA HOME USE LANCETS MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)